These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Bassetti M; Di Biagio A; Rebesco B; Amalfitano ME; Topal J; Bassetti D Eur J Clin Pharmacol; 2001 Sep; 57(6-7):529-34. PubMed ID: 11699621 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the introduction of an antimicrobial drugs formulary in a general hospital in Slovenia. Peklar J; Tratar F; Mrhar A Pharm World Sci; 2004 Dec; 26(6):361-5. PubMed ID: 15683107 [No Abstract] [Full Text] [Related]
8. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Woodward RS; Medoff G; Smith MD; Gray JL Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089 [TBL] [Abstract][Full Text] [Related]
9. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. Gould IM; Jappy B J Antimicrob Chemother; 1996 Nov; 38(5):895-904. PubMed ID: 8961062 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial treatment strategies in hospitalized patients: what role for pharmacoeconomics? Goldman MP; Nair R Cleve Clin J Med; 2007 Aug; 74 Suppl 4():S38-47. PubMed ID: 17847177 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic decision-making: a model for formulary evaluation. Sesin GP Drug Intell Clin Pharm; 1986; 20(7-8):581-3. PubMed ID: 3743414 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic guidelines and antibiotic utilization in Dutch hospitals. Stobberingh E; Janknegt R; Wijnands G J Antimicrob Chemother; 1993 Jul; 32(1):153-61. PubMed ID: 8226406 [TBL] [Abstract][Full Text] [Related]
13. [Clinical results and costs due to improved antibiotics policies]. Gyssens IC; Kullberg BJ; van der Meer JW Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774 [TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective. Huang X; Beresford E; Lodise T; Friedland HD Am J Health Syst Pharm; 2013 Jun; 70(12):1057-64. PubMed ID: 23719884 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic control measures in Dutch secondary care hospitals. Schouten JA; Hulscher ME; Natsch S; Grol RP; van der Meer JW Neth J Med; 2005 Jan; 63(1):24-30. PubMed ID: 15719849 [TBL] [Abstract][Full Text] [Related]
17. Strategic antibiotic decision-making at the formulary level. Quintiliani R; Nightingale CH; Crowe HM; Cooper BW; Bartlett RC; Gousse G Rev Infect Dis; 1991; 13 Suppl 9():S770-7. PubMed ID: 1925323 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements. Thrasher CM; Stefl ME; Dorner FH Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of new antimicrobials for the hospital formulary. Policies restricting antibiotic use in hospitals. Pujol M; Delgado O; Puigventós F; Corzo JE; Cercenado E; Martínez JA Enferm Infecc Microbiol Clin; 2013 Sep; 31 Suppl 4():45-50. PubMed ID: 24129289 [TBL] [Abstract][Full Text] [Related]
20. Results of an antimicrobial control program at a university hospital. Martin C; Ofotokun I; Rapp R; Empey K; Armitstead J; Pomeroy C; Hoven A; Evans M Am J Health Syst Pharm; 2005 Apr; 62(7):732-8. PubMed ID: 15790801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]